ZECHENG ELECTRONICS
837821
Ji Yao Holding Group
300108
Shenzhen Bestek Technology
300822
Jiangsu Canlon Building Materials
300715
Shanghai Hajime Advanced Material Technology
301000
CN Stock MarketDetailed Quotes
688247 Sinotherapeutics Inc.
- 9.91
- 0.000.00%
Market Closed Jan 9 15:00 CST
4.49BMarket Cap40.95P/E (TTM)
10.06High9.78Low17.23KlotVolume9.91Open9.91Pre Close17.10MTurnover1.21%Turnover Ratio73.41P/E (Static)453.34MShares14.0052wk High3.63P/B1.41BFloat Cap6.2352wk Low11.89Limit Up142.32MShs Float27.87Historical High7.93Limit Down2.83%Amplitude6.23Historical Low0.07Dividend TTM9.93Avg Price9.02KlotAsk0.67%Div YieldTTM100Lot Size7.71KlotBid
Sinotherapeutics Inc. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 69.95%362.61M | 96.81%217.99M | 162.65%111.41M | 21.13%299.87M | 14.16%213.36M | -13.37%110.77M | -32.86%42.42M | -21.53%247.56M | -19.15%186.9M | -18.13%127.85M |
| Operating revenue | 69.95%362.61M | 96.81%217.99M | 162.65%111.41M | 21.13%299.87M | 14.16%213.36M | -13.37%110.77M | -32.86%42.42M | -21.53%247.56M | -19.15%186.9M | -18.13%127.85M |
| Total operating cost | 52.82%266.46M | 78.56%164.68M | 118.91%85.56M | 34.11%245.99M | 38.79%174.36M | 3.65%92.23M | -7.97%39.08M | -17.35%183.42M | -23.34%125.63M | -19.79%88.98M |
| Operating cost | 67.80%176.82M | 123.11%111.3M | 227.41%60.77M | 85.70%132.26M | 113.16%105.38M | 42.49%49.88M | 31.39%18.56M | 3.22%71.23M | -5.22%49.43M | 30.15%35.01M |
| Operating tax surcharges | 228.54%2M | 215.10%1.17M | 226.27%576.73K | 289.96%3.03M | 9.16%607.64K | 4.53%370.96K | 1.42%176.77K | 0.42%777.42K | -55.62%556.65K | -68.20%354.88K |
| Operating expense | 22.03%6.84M | 17.44%4.53M | 61.07%2.19M | 33.86%8.17M | 30.09%5.6M | 24.33%3.85M | 3.70%1.36M | 1.61%6.11M | -8.56%4.31M | -9.49%3.1M |
| Administration expense | 6.05%27.72M | 5.64%17.5M | 5.19%7.84M | -5.38%35.76M | -4.90%26.14M | -16.68%16.57M | -13.47%7.46M | -4.82%37.79M | -12.60%27.48M | -16.40%19.89M |
| Financial expense | 50.00%-3.39M | 35.96%-3.88M | -300.17%-1.29M | 14.78%-7.24M | 10.40%-6.77M | -29.84%-6.06M | 274.66%642.1K | -401.31%-8.5M | -595.34%-7.56M | -280.47%-4.66M |
| -Interest expense (Financial expense) | -93.98%2.21K | -95.29%1.67K | -95.06%928.65 | -82.29%37.81K | -76.68%36.69K | -67.02%35.39K | -65.64%18.82K | -7.04%213.52K | -0.41%157.33K | 3.61%107.3K |
| -Interest Income (Financial expense) | 39.64%-3.2M | 51.20%-2.28M | -118.33%-1.09M | -87.55%-6.08M | -170.12%-5.3M | -237.33%-4.67M | 33.97%-497.34K | -119.20%-3.24M | -80.65%-1.96M | -107.77%-1.39M |
| Research and development | 30.08%56.47M | 23.39%34.06M | 41.98%15.45M | -2.65%74.01M | -15.56%43.41M | -21.78%27.61M | -41.50%10.89M | -26.64%76.02M | -29.38%51.41M | -33.56%35.3M |
| Credit Impairment Loss | -722.69%-3.42M | -165.34%-842.4K | -124.63%-398.98K | 43.52%-805.91K | 148.38%549.34K | 254.00%1.29M | 367.19%1.62M | -595.11%-1.43M | -527.50%-1.14M | -181.57%-837.22K |
| Asset Impairment Loss | 110.40%122.82K | -14.61%-1.02M | 83.70%-64K | -159.22%-1.53M | -994.78%-1.18M | -416.68%-891.04K | -277.37%-392.67K | 347.95%2.59M | 118.66%132.02K | 55.67%-172.45K |
| Other net revenue | ||||||||||
| Invest income | -6.99%7M | 21.20%6.36M | -63.58%1.01M | -47.80%11.37M | -19.62%7.52M | -1.93%5.24M | 1.82%2.76M | 421.27%21.78M | 740.05%9.36M | 2,698.08%5.35M |
| -Including: Investment income associates | -75.70%187.39K | 312.79%1.47M | -440.33%-370.9K | -148.29%-2.14M | -80.96%771.18K | -84.36%355.39K | -93.19%108.98K | 726.69%4.43M | 498.61%4.05M | 381.30%2.27M |
| Asset deal income | ---- | ---- | ---- | -47.20%82.09K | --82.09K | --40.09K | ---- | --155.47K | ---- | ---- |
| Other revenue | 52.09%2.92M | 129.26%1.74M | -62.00%189.04K | -49.41%6.02M | -48.66%1.92M | -62.32%758.85K | 20.45%497.52K | -50.22%11.9M | 265.45%3.74M | 199.18%2.01M |
| Operating profit | 114.58%102.77M | 138.39%59.55M | 239.84%26.59M | -30.38%69.01M | -34.72%47.89M | -44.77%24.98M | -66.64%7.82M | -18.28%99.13M | 5.64%73.36M | -4.21%45.23M |
| Add:Non operating Income | -94.72%5.55K | -99.18%824.78 | -33.18%128.32 | 3,949.87%128.14K | 4,783.20%105.15K | 18,322.17%101.11K | 1,920,400.00%192.05 | -99.99%3.16K | -71.93%2.15K | -88.46%548.84 |
| Less:Non operating expense | 637.41%836.06K | 1,035.24%292.06K | --184.53K | 89.78%3.15M | -87.08%113.38K | -97.07%25.73K | ---- | -68.73%1.66M | -75.90%877.23K | -68.57%877.23K |
| Total profit | 112.89%101.94M | 136.51%59.26M | 237.47%26.4M | -32.30%65.99M | -33.94%47.88M | -43.51%25.05M | -65.47%7.82M | -34.59%97.48M | 10.14%72.49M | -0.18%44.35M |
| Less:Income tax cost | 146.35%9.36M | 125.57%5.1M | 3,172.12%3.51M | 8.21%4.92M | -29.40%3.8M | -45.41%2.26M | -95.52%107.2K | -67.77%4.54M | 11.67%5.38M | -44.60%4.14M |
| Net profit | 110.00%92.57M | 137.60%54.15M | 196.71%22.9M | -34.28%61.07M | -34.31%44.08M | -43.31%22.79M | -61.92%7.72M | -31.12%92.93M | 10.02%67.1M | 8.81%40.2M |
| Net profit from continuing operation | 110.00%92.57M | 137.60%54.15M | 196.71%22.9M | -34.28%61.07M | -34.31%44.08M | -43.31%22.79M | -61.92%7.72M | -31.12%92.93M | 10.02%67.1M | 8.81%40.2M |
| Net profit of parent company owners | 110.00%92.57M | 137.60%54.15M | 196.71%22.9M | -34.28%61.07M | -34.31%44.08M | -43.31%22.79M | -61.92%7.72M | -31.12%92.93M | 10.02%67.1M | 8.81%40.2M |
| Earning per share | ||||||||||
| Basic earning per share | 110.00%0.21 | 140.00%0.12 | 150.00%0.05 | -40.91%0.13 | -37.50%0.1 | -50.00%0.05 | -60.00%0.02 | -33.33%0.22 | 6.67%0.16 | 11.11%0.1 |
| Diluted earning per share | 110.00%0.21 | 140.00%0.12 | 150.00%0.05 | -40.91%0.13 | -37.50%0.1 | -50.00%0.05 | -60.00%0.02 | -33.33%0.22 | 6.67%0.16 | 11.11%0.1 |
| Other composite income | -80.38%10.6K | -105.13%-3.51K | 99.56%-107.34 | -88.50%17.98K | -71.74%54.04K | -22.98%68.35K | -231.16%-24.35K | 460.48%156.36K | 1,504.33%191.24K | 533.12%88.74K |
| Other composite income of parent company owners | -80.38%10.6K | -105.13%-3.51K | 99.56%-107.34 | -88.50%17.98K | -71.74%54.04K | -22.98%68.35K | -231.16%-24.35K | 460.48%156.36K | 1,504.33%191.24K | 533.12%88.74K |
| Total composite income | 109.77%92.58M | 136.87%54.15M | 197.64%22.9M | -34.37%61.09M | -34.41%44.14M | -43.26%22.86M | -62.02%7.69M | -30.98%93.09M | 10.36%67.29M | 9.11%40.29M |
| Total composite income of parent company owners | 109.77%92.58M | 136.87%54.15M | 197.64%22.9M | -34.37%61.09M | -34.41%44.14M | -43.26%22.86M | -62.02%7.69M | -30.98%93.09M | 10.36%67.29M | 9.11%40.29M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- | -- | -- |
| Auditor | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.